Literature DB >> 27178850

Increased caffeine intake leads to worsening of electrocorticographic epileptiform discharges as recorded with a responsive neurostimulation device.

Michael J Mackow1, Balu Krishnan2, William E Bingaman2, Imad M Najm2, Andreas V Alexopoulos2, Dileep R Nair2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27178850     DOI： 10.1016/j.clinph.2016.03.012

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN： 1388-2457            Impact factor:   3.708


× No keyword cloud information.
  6 in total

Review 1.  The Use of Caffeine by People with Epilepsy: the Myths and the Evidence.

Authors:  Prisca R Bauer; Josemir W Sander
Journal:  Curr Neurol Neurosci Rep       Date:  2019-05-14       Impact factor: 5.081

2.  Chronic ambulatory electrocorticography from human speech cortex.

Authors:  Vikram R Rao; Matthew K Leonard; Jonathan K Kleen; Ben A Lucas; Emily A Mirro; Edward F Chang
Journal:  Neuroimage       Date:  2017-04-07       Impact factor: 6.556

3.  Seizure localization by chronic ambulatory electrocorticography.

Authors:  Alvin Y Chan; Robert C Knowlton; Edward F Chang; Vikram R Rao
Journal:  Clin Neurophysiol Pract       Date:  2018-04-21

4.  Early detection rate changes from a brain-responsive neurostimulation system predict efficacy of newly added antiseizure drugs.

Authors:  Imran H Quraishi; Michael R Mercier; Tara L Skarpaas; Lawrence J Hirsch
Journal:  Epilepsia       Date:  2019-12-17       Impact factor: 5.864

5.  Individualizing therapies with responsive epilepsy neurostimulation - A mirtazapine case study of hippocampal excitability.

Authors:  Nicole M Warner; Ryder P Gwinn; Michael J Doherty
Journal:  Epilepsy Behav Case Rep       Date:  2016-07-05

6.  Nine-year prospective efficacy and safety of brain-responsive neurostimulation for focal epilepsy.

Authors:  Dileep R Nair; Kenneth D Laxer; Peter B Weber; Anthony M Murro; Yong D Park; Gregory L Barkley; Brien J Smith; Ryder P Gwinn; Michael J Doherty; Katherine H Noe; Richard S Zimmerman; Gregory K Bergey; William S Anderson; Christianne Heck; Charles Y Liu; Ricky W Lee; Toni Sadler; Robert B Duckrow; Lawrence J Hirsch; Robert E Wharen; William Tatum; Shraddha Srinivasan; Guy M McKhann; Mark A Agostini; Andreas V Alexopoulos; Barbara C Jobst; David W Roberts; Vicenta Salanova; Thomas C Witt; Sydney S Cash; Andrew J Cole; Gregory A Worrell; Brian N Lundstrom; Jonathan C Edwards; Jonathan J Halford; David C Spencer; Lia Ernst; Christopher T Skidmore; Michael R Sperling; Ian Miller; Eric B Geller; Michel J Berg; A James Fessler; Paul Rutecki; Alica M Goldman; Eli M Mizrahi; Robert E Gross; Donald C Shields; Theodore H Schwartz; Douglas R Labar; Nathan B Fountain; W Jeff Elias; Piotr W Olejniczak; Nicole R Villemarette-Pittman; Stephan Eisenschenk; Steven N Roper; Jane G Boggs; Tracy A Courtney; Felice T Sun; Cairn G Seale; Kathy L Miller; Tara L Skarpaas; Martha J Morrell
Journal:  Neurology       Date:  2020-07-20       Impact factor: 9.910
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.